BXMPY (Beximco Pharmaceuticals) Accounts Payable: $17.22 Mil (As of Mar. 2026)


What is Beximco Pharmaceuticals Accounts Payable?

Beximco Pharmaceuticals BXMPY 92 Accounts Payable is $17.22 Mil as of Mar. 2026. GuruFocus rates BXMPY with a GF Score™ of 92/100. The stock has 5 warning signs investors should review.

Beximco Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2026 was $17.22 Mil.

Beximco Pharmaceuticals's quarterly Accounts Payable increased from Sep. 2025 ($22.88 Mil) to Dec. 2025 ($23.00 Mil) but then declined from Dec. 2025 ($23.00 Mil) to Mar. 2026 ($17.22 Mil).

Beximco Pharmaceuticals's annual Accounts Payable declined from Jun. 2023 ($13.12 Mil) to Jun. 2024 ($11.36 Mil) but then increased from Jun. 2024 ($11.36 Mil) to Jun. 2025 ($12.68 Mil).

Beximco Pharmaceuticals Accounts Payable Related Terms

Beximco Pharmaceuticals Accounts Payable Historical Data

* Premium members only.

The historical data trend for Beximco Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals Accounts Payable Chart

Beximco Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.23 11.13 13.12 11.36 12.68

Beximco Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 12.68 22.88 23.00 17.22

Beximco Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $17.22 Mil mean?
Beximco Pharmaceuticals (BXMPY) has a Accounts Payable of $17.22 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Beximco Pharmaceuticals and its competitors.
Is Beximco Pharmaceuticals' Accounts Payable too high?
Beximco Pharmaceuticals' current Accounts Payable is $17.22 Mil. Overall, Beximco Pharmaceuticals has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' Accounts Payable compare to ZTS and UTHR?
Beximco Pharmaceuticals' Accounts Payable of $17.22 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Beximco Pharmaceuticals and its competitors. Beximco Pharmaceuticals's current Accounts Payable is $17.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Beximco Pharmaceuticals (BXMPY) has a current Accounts Payable of $17.22 Mil. The current Accounts Payable is $17.22 Mil. Beximco Pharmaceuticals' overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Beximco Pharmaceuticals (BXMPY), the current Accounts Payable is $17.22 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beximco Pharmaceuticals Business Description

Address 19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.